By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Chiesi Farmaceutici SpA 

Via Palermo 26/ A

Parma    43100  Italy
Phone: 39-0521-279-230 Fax: 39-0521-774468



Company News
The Medicines Company (MDCO) Agrees To Divest Non-Core Cardiovascular Assets To Chiesi Farmaceutici SpA 5/9/2016 11:13:23 AM
The Medicines Company (MDCO) Divests Cardiovascular Assets to Chiesi Farmaceutici SpA for Up to $792 Million 5/9/2016 6:02:25 AM
Kamada Ltd. (KMDA) Receives Two Milestone Payments Under Strategic Agreements With Chiesi Farmaceutici SpA And Baxalta (BXLT) 5/2/2016 9:48:17 AM
uniQure And Chiesi Farmaceutici SpA Announce Six Year Follow-up Data from Glybera® Treated Patients 3/17/2014 8:58:30 AM
Chiesi Farmaceutici SpA Completes Acquisition Of Cornerstone Therapeutics Inc. 2/4/2014 9:58:06 AM
Selvita Extends Long-Term Chemistry Collaboration With Chiesi Farmaceutici SpA 1/10/2014 10:12:55 AM
Chiesi Farmaceutici SpA to Buy Rest of Cornerstone Therapeutics Inc. for $255 Million 9/16/2013 6:52:01 AM
CereSpir Incorporated Announces Letter of Intent With Chiesi Farmaceutici SpA to License Worldwide Development and Commercialization Rights for CHF 5074 to CereSpir 7/26/2013 10:01:33 AM
CereSpir Incorporated is Pleased With Positive Interim Phase 2 Results for CHF 5074 in Patients With Mild Cognitive Impairment, Presented by Chiesi Farmaceutici SpA at the AAIC 2013 Meeting in Boston 7/26/2013 9:53:35 AM
uniQure, Chiesi Farmaceutici SpA Strike $58 Million Deal for Hemophilia B Development 7/9/2013 7:30:38 AM